Stephen W. Webster's most recent trade in Nextcure Inc was a trade of 18,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 18,700 | 18,700 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 38,513 | 38,513 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 09 Jun 2025 | 4,244 | 26,662 (0%) | 0% | 11.8 | 50,207 | Ordinary Shares |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,304 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,304 | 26,979 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,790 | 5,370 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,790 | 30,831 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,070 | 2,140 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,070 | 28,949 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,000 | 1,000 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 1,000 | 24,550 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 900 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 900 | 27,879 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 800 | 23,422 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 800 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 128 | 0 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 128 | 23,550 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 125 | 144 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 125 | 24,675 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 92 | 236 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 92 | 29,041 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 75 | 230 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 75 | 30,906 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.53 per share. | 22 May 2025 | 1,475 | 22,622 (0%) | 0% | 11.5 | 17,007 | Ordinary Shares |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 103,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 25,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 7,379 | 0 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 6,240 | 6,240 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 2,304 | 2,304 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 900 | 900 | - | - | Stock Options (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,700 | 18,700 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 7,379 | 7,379 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 103,600 | 103,600 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster M.D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.67 per share. | 20 Mar 2024 | 2,043 | 20,431 (0%) | 0% | 10.7 | 21,799 | Ordinary Shares |
| Luxfer Holdings PLC | M.D. Stephen Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,070 | 3,210 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | M.D. Stephen Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,070 | 22,423 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Webster Stephen M.D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | M.D. Webster Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,000 | 20,388 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Webster M.D. Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 800 | 21,266 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | M.D. Stephen Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 800 | 800 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | M.D. Stephen Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 750 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster M.D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 750 | 19,261 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen Webster M.D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 127 | 0 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 127 | 19,388 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 87 | 21,353 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | M.D. Webster Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 87 | 92 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | M.D. Stephen Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 78 | 20,466 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Webster M.D. Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 78 | 165 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | M.D. Webster Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 51 | 22,474 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Webster M.D. Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 51 | 160 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 7,160 | 7,160 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.46 per share. | 17 Nov 2023 | 1,200 | 18,025 (0%) | 0% | 8.5 | 10,152 | Ordinary Shares |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 4,280 | 4,280 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.39 per share. | 16 Mar 2023 | 1,783 | 16,138 (0%) | 0% | 15.4 | 27,440 | Ordinary Shares |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 1,000 | 17,878 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 1,000 | 3,000 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 800 | 16,833 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 800 | 1,600 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 750 | 750 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 750 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 750 | 15,968 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 750 | 15,116 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 102 | 0 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 102 | 15,218 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 65 | 16,033 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 65 | 88 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 45 | 16,878 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 45 | 97 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 43 | 17,921 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 43 | 91 | - | - | Dividend Equivalent Rights | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.92 per share. | 23 May 2022 | 3,240 | 13,805 (0%) | 0% | 15.9 | 51,580 | Ordinary Shares |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 2,000 | 12,698 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 2,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 1,500 | 14,384 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 1,500 | 15,993 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 1,500 | 750 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 1,500 | 1,500 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 800 | 16,859 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 800 | 2,400 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 186 | 12,884 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 186 | 0 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 167 | 0 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 167 | 17,045 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 109 | 14,493 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 109 | 83 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 66 | 16,059 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 66 | 113 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 19 | 16,878 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 19 | 80 | - | - | Dividend Equivalent Rights | |
| Luxfer Holdings PLC | Stephen M.D. Webster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 4,000 | 4,000 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 1,800 | 0 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 1,800 | 11,323 (0%) | 0% | - | Ordinary Shares | |
| Luxfer Holdings PLC | Stephen Webster | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.41 per share. | 01 Dec 2021 | 879 | 10,444 (0%) | 0% | 19.4 | 17,057 | Ordinary Shares |
| Nextcure Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 3,200 | 3,200 | - | - | Stock Options (Right to Buy) | |
| Luxfer Holdings PLC | Stephen Webster | Corporate Controller | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 09 Nov 2020 | 1,500 | 9,222 (0%) | 0% | 13.3 | 19,994 | Ordinary Shares |